GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Medlander Medical Technology Co Ltd (SHSE:688273) » Definitions » Cash, Cash Equivalents, Marketable Securities

Nanjing Medlander Medical Technology Co (SHSE:688273) Cash, Cash Equivalents, Marketable Securities : ¥1,024.8 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Nanjing Medlander Medical Technology Co Cash, Cash Equivalents, Marketable Securities?

Nanjing Medlander Medical Technology Co's quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 (¥1,109.04 Mil) to Dec. 2023 (¥1,097.28 Mil) but then stayed the same from Dec. 2023 (¥1,097.28 Mil) to Mar. 2024 (¥1,024.78 Mil).

Nanjing Medlander Medical Technology Co's annual cash, cash equivalents, marketable securities increased from Dec. 2021 (¥272.62 Mil) to Dec. 2022 (¥1,215.83 Mil) but then declined from Dec. 2022 (¥1,215.83 Mil) to Dec. 2023 (¥1,097.28 Mil).


Nanjing Medlander Medical Technology Co Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Nanjing Medlander Medical Technology Co's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Medlander Medical Technology Co Cash, Cash Equivalents, Marketable Securities Chart

Nanjing Medlander Medical Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial 101.95 149.82 272.62 1,215.83 1,097.28

Nanjing Medlander Medical Technology Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,237.17 1,133.53 1,109.04 1,097.28 1,024.78

Nanjing Medlander Medical Technology Co Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Nanjing Medlander Medical Technology Co  (SHSE:688273) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Nanjing Medlander Medical Technology Co Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Nanjing Medlander Medical Technology Co's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Medlander Medical Technology Co (SHSE:688273) Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Gande Road, 2nd Floor, Building 5, Jiangning High-tech Park, Jiangning District, Jiangsu Province, Nanjing City, CHN, 211100
Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales and service of related products in the field of pelvic floor and postpartum rehabilitation.
Executives
Zhu Bi Sheng senior management
Chen Jiang Ning senior management
Yang Rui Jia Directors, senior managers, core technical personn
Shi Zhi Huai Directors, senior managers, core technical personn
Chen Bin Directors, senior managers
Tu Hong Lin Directors, senior managers
Wang Wang senior management

Nanjing Medlander Medical Technology Co (SHSE:688273) Headlines

No Headlines